Cancer Research UK logo.
SearchDonate
  • Search

A trial of 2 treatments for advanced neuroendrocrine tumours of the pancreas (SEQTOR)

Overview

Cancer types:

Neuroendocrine tumour (NET), Secondary cancers

Status:

Closed

Phase:

Phase 3

Details

This trial is looking at the order of treatment for people with neuroendocrine tumours of the pancreas (pNETs).

It is for people who have a NET that has spread elsewhere in the body and that cannot be removed with surgery. This is advanced or metastatic cancer.

Recruitment start: 9 December 2005

Recruitment end: 16 April 2019

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Nicholas Simon Reed

Supported by

Grupo Español de Tumores Neuroendocrinos (GENTE)

Novartis Pharmaceuticals UK

Kantar Health

Last reviewed: 20 July 2020

CRUK internal database number: 15508

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.